Aurora Spine Corporation is a healthcare company that specializes in providing technology-driven medical devices and instruments for spinal implants and surgeries. Aurora Spine Corporation is a public company listed on the Toronto Venture Stock Exchange – the Canadian market – with its common shares trading under the ticker symbol ASG. The medical device provider also lists and trades its common shares on the OTCQB market in the United States under the stock symbol ASAPF.
The Toronto-based company is involved in the designing, development, manufacturing and commercialization of interspinous fusion systems and instruments. The company offers the following spinal fusion systems:
i. SILOTM for SI joint pain
ii. ZIP UltraTM Spinal Fusion
iii. ZIP 51TM Spinal Fusion
iv. ZIP LPTM Spinal Fusion
Aurora Spine Corporation works on regenerative spinal implant tech, that is least invasive and improves surgical results. The spinal implant and surgery-focused product portfolio of Aurora includes various device systems and instruments under different product lines:
• Cervical and Thoraco Lumbar Implants
i. DiscoveryTM ACIF Interbody Fusion
ii. ApolloTM Anterior Cervical Plate
• Surgical tools
i. Anterior Disc Prep
ii. Posterior Disc Prep
iii. Compass 4D Retractor System
i. ZIP GraftTM Amniotic fluid
• Non-Fusion System
i. ZIP FlexTM
The company primarily earns by marketing and selling its proprietary and patented spinal implant fusion systems and technologies.
In August 2021, the company received clearance for its proprietary and patented DEXA TechnologyTM from the Unites States Food and Drug Administration. DEXA is a fresh product line for anterior cervical discectomy with fusion procedured, i.e., customized implants according to the bone density of patients. This fusion technology aims to boost bone growth and long-term fixation. Aurora is focused on innovating and developing new medical technologies and solutions to advance the global spinal implant market.